Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies

28Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.
Get full text

Abstract

An increase in life expectancy in developed countries has led to a surge of chronic aging-related diseases. In the last few decades, several studies have provided evidence of the prominent role of cellular senescence in many of these pathologies. Key traits of senescent cells include cell cycle arrest, apoptosis resistance, and secretome shift to senescence-associated secretory phenotype resulting in increased secretion of various intermediate bioactive factors important for senescence pathophysiology. However, cellular senescence is a highly phenotypically heterogeneous process, hindering the discovery of totally specific and accurate biomarkers. Also, strategies to prevent the stage, and potential for human applicability of the main existing senotherapeutic strategies.

Cite

CITATION STYLE

APA

Lucas, V., Cavadas, C., & Aveleira, C. A. (2023). Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies. Pharmacological Reviews, 75(4), 675–713. https://doi.org/10.1124/pharmrev.122.000622

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free